| Trial ID: | L1141 |
| Source ID: | NCT00382044
|
| Associated Drug: |
Eprex; Neorecormon; Aranesp
|
| Title: |
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic|Anemia
|
| Interventions: |
DRUG: Eprex; Neorecormon; Aranesp
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Sir Charles Gairdner Hospital
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
150
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2006-09
|
| Completion Date: |
2008-04
|
| Results First Posted: |
|
| Last Update Posted: |
2008-05-23
|
| Locations: |
Sir Charles Gairdner Hospital, Perth, Western Australia, 6009, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT00382044
|
